MLDL1278A

DRUG2 trials

Sponsors

Genentech, Inc., BioInvent International AB

Conditions

AtherosclerosisHealthy

Phase 1

Bioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects

CompletedNCT01486823

BioInvent International ABHealthy

Start: 2011-11-30End: 2012-07-31Updated: 2012-12-11

Phase 2

A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)

CompletedNCT01258907

Genentech, Inc.Atherosclerosis

Start: 2010-03-31Updated: 2016-11-02